Subscribe to RSS
DOI: 10.1055/s-0029-1246043
© Georg Thieme Verlag KG Stuttgart · New York
Aktuelle molekular-zytogenetische Aspekte zur Pathologie und Differenzierung von extranodalen Marginalzonen B-Zell-Lymphomen vom MALT-Typ und gastrointestinalen diffusen großzelligen B-Zell-Lymphomen
Current Aspects of the Pathology and Differentiation of Extranodal Marginal Zone B-Cell Lymphoma, MALT-Type, and Gastrointestinal Diffuse Large B-Cell LymphomaPublication History
eingereicht: 23.12.2009
angenommen: 19.4.2010
Publication Date:
01 February 2011 (online)

Zusammenfassung
Das Marginalzonen B-Zell-Lymphom vom MALT-Typ (MZBL, MT) ist ein häufig im Magen lokalisiertes, niedrig malignes B-Zell-Lymphom mit typischer Morphologie und Zytogenetik. Daneben existieren das gastrointestinale diffuse großzellige B-Zell-Lymphom (DLBCL) und Kompositlymphome (ComL) mit koexistenter groß- und kleinzelliger Zytologie, die aufgrund dessen ein faszinierendes Modell hinsichtlich der Lymphomprogression darstellen. Im vorliegenden Review werden die wichtigsten aktuellen Aspekte zur molekularen Charakterisierung der MZBL, MT und der gastrointestinalen DLBCL sowie einer Relation dieser Lymphomentitäten untereinander zusammengefasst, die sie klar von den nodalen DLBCL abgrenzen.
Abstract
The marginal zone B-cell lymphoma, MALT-type (MZBL, MT) is a low-grade B-cell lymphoma which is predominantly localised in the stomach with a typical morphology and cytogenetic pattern. The coexistence of a diffuse large B-cell lymphoma (DLBCL) with an MZBL, MT in the gastrointestinal tract is defined as a composite lymphoma (ComL) and represents a fascinating model of lymphoma progression. In this review we focus on current aspects regarding the molecular characterisation of MZBL, MT and gastrointestinal DLBCL and their mutual relationships.
Schlüsselwörter
MALT-Lymphom - gastrales DLBCL - Molekularbiologie
Key words
MALT lymphom - gastric DLBCL - molecular biology
Literatur
- 1
d’Amore F, Christensen B E, Brincker H et al.
Clinicopathological features and prognostic factors in extranodal non-Hodgkin lymphomas.
Danish LYFO Study Group.
Eur J Cancer.
1991;
27
1201-1208
MissingFormLabel
- 2
Zheng T, Mayne S T, Boyle P et al.
Epidemiology of non-Hodgkin lymphoma in Connecticut. 1935 – 1988.
Cancer.
1992;
70
840-849
MissingFormLabel
- 3
A clinical evaluation of the International Lymphoma Study Group classification of
non-Hodgkin’s lymphoma. The Non-Hodgkin’s Lymphoma Classification Project.
Blood.
1997;
89
3909-3918
MissingFormLabel
- 4
Newton R, Ferlay J, Beral V et al.
The epidemiology of non-Hodgkin’s lymphoma: comparison of nodal and extra-nodal sites.
Int J Cancer.
1997;
72
923-930
MissingFormLabel
- 5
Hussell T, Isaacson P G, Crabtree J E et al.
The response of cells from low-grade B-cell gastric lymphomas of mucosa-associated
lymphoid tissue to Helicobacter pylori.
Lancet.
1993;
342
571-574
MissingFormLabel
- 6
Greiner A, Marx A, Heesemann J et al.
Idiotype identity in a MALT-type lymphoma and B cells in Helicobacter pylori associated
chronic gastritis.
Lab Invest.
1994;
70
572-578
MissingFormLabel
- 7
Isaacson P G, Du M Q.
MALT lymphoma: from morphology to molecules.
Nat Rev Cancer.
2004;
4
644-653
MissingFormLabel
- 8
Isaacson P G, Chott A, Nakamura S et al.
Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma).
World Health Organization Classification of Tumours of Hematopoietic and Lymphoid
Tisues.
Swerdlow SH Campo E Harris NL et al..
2008;
214-217
MissingFormLabel
- 9
Wotherspoon A C, Ortiz-Hidalgo C, Falzon M R et al.
Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma.
Lancet.
1991;
338
1175-1176
MissingFormLabel
- 10
Karat D, O’Hanlon D M, Hayes N et al.
Prospective study of Helicobacter pylori infection in primary gastric lymphoma.
Br J Surg.
1995;
82
1369-1370
MissingFormLabel
- 11
Bouzourene H, Haefliger T, Delacretaz F et al.
The role of Helicobacter pylori in primary gastric MALT lymphoma.
Histopathology.
1999;
34
118-123
MissingFormLabel
- 12
Lecuit M, Abachin E, Martin A et al.
Immunoproliferative small intestinal disease associated with Campylobacter jejuni.
N Engl J Med.
2004;
350
239-248
MissingFormLabel
- 13
Wundisch T, Mosch C, Neubauer A et al.
Helicobacter pylori eradication in gastric mucosa-associated lymphoid tissue lymphoma:
Results of a 196-patient series.
Leuk Lymphoma.
2006;
47
2110-2114
MissingFormLabel
- 14
Bayerdorffer E, Neubauer A, Rudolph B et al.
Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after
cure of Helicobacter pylori infection. MALT Lymphoma Study Group.
Lancet.
1995;
345
1591-1594
MissingFormLabel
- 15
Du M Q, Isaccson P G.
Gastric MALT lymphoma: from aetiology to treatment.
Lancet Oncol.
2002;
3
97-104
MissingFormLabel
- 16
Fischbach W, Malfertheiner P, Hoffmann J C et al.
S3-guideline ”helicobacter pylori and gastroduodenal ulcer disease” of the German
society for digestive and metabolic diseases (DGVS) in cooperation with the German
society for hygiene and microbiology, society for pediatric gastroenterology and nutrition
e. V., German society for rheumatology, AWMF-registration-no. 021 / 001.
Z Gastroenterol.
2009;
47
1230-1263
MissingFormLabel
- 17
Koch P, Probst A, Berdel W E et al.
Treatment results in localized primary gastric lymphoma: data of patients registered
within the German multicenter study (GIT NHL 02 / 96).
J Clin Oncol.
2005;
23
7050-7059
MissingFormLabel
- 18
Hussell T, Isaacson P G, Crabtree J E et al.
Helicobacter pylori-specific tumour-infiltrating T cells provide contact dependent
help for the growth of malignant B cells in low-grade gastric lymphoma of mucosa-associated
lymphoid tissue.
J Pathol.
1996;
178
122-127
MissingFormLabel
- 19
Nakamura S, Aoyagi K, Furuse M et al.
B-cell monoclonality precedes the development of gastric MALT lymphoma in Helicobacter
pylori-associated chronic gastritis.
Am J Pathol.
1998;
152
1271-1279
MissingFormLabel
- 20
Ott G, Katzenberger T, Greiner A et al.
The t(11;18)(q21;q21) chromosome translocation is a frequent and specific aberration
in low-grade but not high-grade malignant non-Hodgkin’s lymphomas of the mucosa-associated
lymphoid tissue (MALT-) type.
Cancer Res.
1997;
57
3944-3948
MissingFormLabel
- 21
Auer I A, Gascoyne R D, Connors J M et al.
t(11;18)(q21;q21) is the most common translocation in MALT lymphomas.
Ann Oncol.
1997;
8
979-985
MissingFormLabel
- 22
Remstein E D, James C D, Kurtin P J.
Incidence and subtype specificity of API2-MALT1 fusion translocations in extranodal,
nodal, and splenic marginal zone lymphomas.
Am J Pathol.
2000;
156
1183-1188
MissingFormLabel
- 23
Ye H, Liu H, Attygalle A et al.
Variable frequencies of t(11;18)(q21;q21) in MALT lymphomas of different sites: significant
association with CagA strains of H pylori in gastric MALT lymphoma.
Blood.
2003;
102
1012-1018
MissingFormLabel
- 24
Remstein E D, Kurtin P J, James C D et al.
Mucosa-associated lymphoid tissue lymphomas with t(11;18)(q21;q21) and mucosa-associated
lymphoid tissue lymphomas with aneuploidy develop along different pathogenetic pathways.
Am J Pathol.
2002;
161
63-71
MissingFormLabel
- 25
Uren A G, O’Rourke K, Aravind L A et al.
Identification of paracaspases and metacaspases: two ancient families of caspase-like
proteins, one of which plays a key role in MALT lymphoma.
Mol Cell.
2000;
6
961-967
MissingFormLabel
- 26
Lucas P C, Yonezumi M, Inohara N et al.
Bcl10 and MALT1, independent targets of chromosomal translocation in malt lymphoma,
cooperate in a novel NF-kappa B signaling pathway.
J Biol Chem.
2001;
276
19 012-19 019
MissingFormLabel
- 27
Liu H, Ye H, Ruskone-Fourmestraux A et al.
T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to
H. pylori eradication.
Gastroenterology.
2002;
122
1286-1294
MissingFormLabel
- 28
Liu H, Ye H, Dogan A et al.
T(11;18)(q21;q21) is associated with advanced mucosa-associated lymphoid tissue lymphoma
that expresses nuclear BCL10.
Blood.
2001;
98
1182-1187
MissingFormLabel
- 29
Streubel B, Simonitsch-Klupp I, Mullauer L et al.
Variable frequencies of MALT lymphoma-associated genetic aberrations in MALT lymphomas
of different sites.
Leukemia.
2004;
18
1722-1726
MissingFormLabel
- 30
Du M, Peng H, Singh N et al.
The accumulation of p53 abnormalities is associated with progression of mucosa-associated
lymphoid tissue lymphoma.
Blood.
1995;
86
4587-4593
MissingFormLabel
- 31
Neumeister P, Hoefler G, Beham-Schmid C et al.
Deletion analysis of the p16 tumor suppressor gene in gastrointestinal mucosa-associated
lymphoid tissue lymphomas.
Gastroenterology.
1997;
112
1871-1875
MissingFormLabel
- 32
Barth T F, Bentz M, Leithauser F et al.
Molecular-cytogenetic comparison of mucosa-associated marginal zone B-cell lymphoma
and large B-cell lymphoma arising in the gastro-intestinal tract. Genes Chromosomes.
Cancer.
2001;
31
316-325
MissingFormLabel
- 33
Zhou Y, Ye H, Martin-Subero J I et al.
Distinct comparative genomic hybridisation profiles in gastric mucosa-associated lymphoid
tissue lymphomas with and without t(11;18)(q21;q21).
Br J Haematol.
2006;
133
35-42
MissingFormLabel
- 34
Barth T F, Bentz M, Leithauser F et al.
Pathogenic complexity of gastric B-cell lymphoma.
Blood.
2002;
100
1095-1096
MissingFormLabel
- 35
Cabras A D, Candidus S, Fend F et al.
Biclonality of gastric lymphomas.
Lab Invest.
2001;
81
961-967
MissingFormLabel
- 36
Barth T F, Dohner H, Werner C A et al.
Characteristic pattern of chromosomal gains and losses in primary large B-cell lymphomas
of the gastrointestinal tract.
Blood.
1998;
91
4321-4330
MissingFormLabel
- 37
Streubel B, Lamprecht A, Dierlamm J et al.
T(14;18)(q32;q21) involving IGH and MALT1 is a frequent chromosomal aberration in
MALT lymphoma.
Blood.
2003;
101
2335-2339
MissingFormLabel
- 38
Ye H, Gong L, Liu H et al.
MALT lymphoma with t(14;18)(q32;q21)/IGH-MALT1 is characterized by strong cytoplasmic
MALT1 and BCL10 expression.
J Pathol.
2005;
205
293-301
MissingFormLabel
- 39
Sanchez-Izquierdo D, Buchonnet G, Siebert R et al.
MALT1 is deregulated by both chromosomal translocation and amplification in B-cell
non-Hodgkin lymphoma.
Blood.
2003;
101
4539-4546
MissingFormLabel
- 40
Dierlamm J, Murga Penas E M, Bentink S et al.
Gain of chromosome region 18q21 including the MALT1 gene is associated with the activated
B-cell-like gene expression subtype and increased BCL2 gene dosage and protein expression
in diffuse large B-cell lymphoma.
Haematologica.
2008;
93
688-696
MissingFormLabel
- 41
Willis T G, Jadayel D M, Du M Q et al.
Bcl10 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple
tumor types.
Cell.
1999;
96
35-45
MissingFormLabel
- 42
Zhang Q, Siebert R, Yan M et al.
Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing
gene, in MALT lymphoma with t(1;14)(p22;q32).
Nat Genet.
1999;
22
63-68
MissingFormLabel
- 43
Ye H, Gong L, Liu H et al.
Strong BCL10 nuclear expression identifies gastric MALT lymphomas that do not respond
to H pylori eradication.
Gut.
2006;
55
137-138
MissingFormLabel
- 44
Thome MCARMA1, BCL-10 and MALT1 in lymphocyte development and activation.
Nat Rev Immunol.
2004;
4
348-359
MissingFormLabel
- 45
Dong G, Liu C, Ye H et al.
BCL10 nuclear expression and t(11;18)(q21;q21) indicate nonresponsiveness to Helicobacter
pylori eradication of Chinese primary gastric MALT lymphoma.
Int J Hematol.
2008;
88
516-523
MissingFormLabel
- 46
Ohshima K, Kawasaki C, Muta H et al.
CD10 and Bcl10 expression in diffuse large B-cell lymphoma: CD 10 is a marker of improved
prognosis.
Histopathology.
2001;
39
156-162
MissingFormLabel
- 47
Streubel B, Vinatzer U, Lamprecht A et al.
T(3;14)(p14.1;q32) involving IGH and FOXP1 is a novel recurrent chromosomal aberration
in MALT lymphoma.
Leukemia.
2005;
19
652-658
MissingFormLabel
- 48
Wlodarska I, Veyt E, Paepe de P et al.
FOXP1, a gene highly expressed in a subset of diffuse large B-cell lymphoma, is recurrently
targeted by genomic aberrations.
Leukemia.
2005;
19
1299-1305
MissingFormLabel
- 49
Fenton J A, Schuuring E, Barrans S L et al.
t(3;14)(p14;q32) results in aberrant expression of FOXP1 in a case of diffuse large
B-cell lymphoma. Genes Chromosomes.
Cancer.
2006;
45
164-168
MissingFormLabel
- 50
Ye H, Remstein E D, Bacon C M et al.
Chromosomal translocations involving BCL6 in MALT lymphoma.
Haematologica.
2008;
93
145-146
MissingFormLabel
- 51
Chen Y W, Hu X T, Liang A C et al.
High BCL6 expression predicts better prognosis, independent of BCL6 translocation
status, translocation partner, or BCL6-deregulating mutations, in gastric lymphoma.
Blood.
2006;
108
2373-2383
MissingFormLabel
- 52
Remstein E D, Dogan A, Einerson R R et al.
The incidence and anatomic site specificity of chromosomal translocations in primary
extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT
lymphoma) in North America.
Am J Surg Pathol.
2006;
30
1546-1553
MissingFormLabel
- 53
Nakamura S, Ye H, Bacon C M et al.
Clinical impact of genetic aberrations in gastric MALT lymphoma: a comprehensive analysis
using interphase fluorescence in situ hybridisation.
Gut.
2007;
56
1358-1363
MissingFormLabel
- 54
Vinatzer U, Gollinger M, Mullauer L et al.
Mucosa-associated lymphoid tissue lymphoma: novel translocations including rearrangements
of ODZ2, JMJD2C, and CNN3.
Clin Cancer Res.
2008;
14
6426-6431
MissingFormLabel
- 55
Nakamura S, Ye H, Bacon C M et al.
Translocations involving the immunoglobulin heavy chain gene locus predict better
survival in gastric diffuse large B-cell lymphoma.
Clin Cancer Res.
2008;
14
3002-3010
MissingFormLabel
- 56
Barth T F, Barth C A, Kestler H A et al.
Transcriptional profiling suggests that secondary and primary large B-cell lymphomas
of the gastrointestinal (GI) tract are blastic variants of GI marginal zone lymphoma.
J Pathol.
2007;
211
305-313
MissingFormLabel
Lucia Floßbach
Institut für Pathologie, Universitätsklinikum Ulm
Albert-Einstein-Allee 11
89081 Ulm
Email: lucia.flossbach@uni-ulm.de